Leptomeningeal metastases in the MRI era.

Carcinomatous meningitis: Leptomeningeal metastases in solid tumors. Surg Neurol Int (2013) 2.12

Alectinib salvages CNS relapses in ALK-positive lung cancer patients previously treated with crizotinib and ceritinib. J Thorac Oncol (2015) 1.50

Detection of cancer cells in the cerebrospinal fluid: current methods and future directions. Fluids Barriers CNS (2011) 1.32

Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials. Neuro Oncol (2014) 1.12

Neoplastic leptomeningitis presenting in a melanoma patient treated with dabrafenib (a V600EBRAF inhibitor): a case report. J Med Case Rep (2012) 1.09

Leptomeningeal metastases in breast cancer. Am J Cancer Res (2013) 1.00

Neoplastic meningitis from solid tumors: new diagnostic and therapeutic approaches. Oncologist (2011) 0.99

Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid. J Clin Oncol (2016) 0.94

Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors. Neurology (2013) 0.94

Potential of F-18 PET/CT in the Detection of Leptomeningeal Metastasis. Neuroradiol J (2014) 0.94

Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report. Neurology (2013) 0.93

Meningeal carcinomatosis underdiagnosis and overestimation: incidence in a large consecutive and unselected population of breast cancer patients. BMC Cancer (2015) 0.86

Leptomeningeal metastases in the MRI era. Neurology (2011) 0.84

Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge. Neurol Sci (2014) 0.84

Radiation therapy for epithelial ovarian cancer brain metastases: clinical outcomes and predictors of survival. Radiat Oncol (2013) 0.82

Frequent development of leptomeningeal carcinomatosis in patients with peritoneal dissemination of gastric cancer. Gastric Cancer (2011) 0.81

Nonenhancing Leptomeningeal Metastases: Imaging Characteristics and Potential Causative Factors. Neurohospitalist (2016) 0.80

Leptomeningeal carcinomatosis as initial presentation in adenocarcinoma of lung with signet ring cell features: an autopsy case report. Int J Clin Exp Pathol (2012) 0.80

Leptomeningeal metastases: a RANO proposal for response criteria. Neuro Oncol (2017) 0.79

Numb chin syndrome secondary to leptomeningeal carcinomatosis from gastric adenocarcinoma. J Gastrointest Oncol (2015) 0.79

Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report. BMC Cancer (2015) 0.78

The shifting landscape of metastatic breast cancer to the CNS. Neurosurg Rev (2012) 0.78

Meningeal carcinomatosis diagnosed during stroke evaluation in the emergency department. Int J Emerg Med (2011) 0.77

Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study. Int J Cancer (2016) 0.76

Leptomeningeal carcinomatosis in a patient with gallbladder carcinoma. J Cytol (2017) 0.75

An unusual presentation of carcinomatous meningitis. Oxf Med Case Reports (2016) 0.75

Gadobutrol-enhanced magnetic resonance imaging of meningeal carcinomatosis: case report with emphasis on early diagnosis. BMC Neurol (2016) 0.75

Electrographic Correlates of Plateau Waves in Patients With Leptomeningeal Metastases. Neurohospitalist (2016) 0.75

Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis. Cell (2017) 0.75

Leptomeningeal disease in oligodendroglial tumors: a population-based study. J Neurooncol (2011) 0.75

Cerebrospinal fluid dissemination of anaplastic intraventricular meningioma: report of a case presenting with progressive brainstem dysfunction and multiple cranial nerve palsies. BMC Neurol (2016) 0.75

Non-small cell lung cancer (NSCLC) and central nervous system (CNS) metastases: role of tyrosine kinase inhibitors (TKIs) and evidence in favor or against their use with concurrent cranial radiotherapy. Transl Lung Cancer Res (2016) 0.75

Clinical Reasoning: Worsening neurologic symptoms in a brain tumor patient. Neurology (2015) 0.75

Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis. Clin Breast Cancer (2016) 0.75

Bilateral Facial Nerve Paralysis as First Presentation of Lung Cancer. Case Rep Oncol (2016) 0.75

Novel method for the detection and quantification of malignant cells in the CSF of patients with leptomeningeal metastasis of lung cancer. Oncol Lett (2015) 0.75

Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis. Cancer Res Treat (2015) 0.75

Neoplastic meningitis: How MRI and CSF cytology are influenced by CSF cell count and tumor type. ScientificWorldJournal (2013) 0.75

An Unusual Presentation of Isolated Leptomeningeal Disease in Carcinoma of Unknown Primary With Pancreatic Features. J Investig Med High Impact Case Rep (2013) 0.75

Acute kidney injury and inflammatory immune reconstitution syndrome in mixed genotype (A/E) hepatitis B virus co-infection in HIV-associated lymphoma. Int J Clin Exp Pathol (2013) 0.75

Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study. Breast Cancer Res (2017) 0.75

Diagnostic value of circulating tumor cells in cerebrospinal fluid. Open Med (Wars) (2016) 0.75

Back pain in a patient with lung cancer. J Adv Pract Oncol (2012) 0.75

Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future Directions. Int J Mol Sci (2016) 0.75

Detection value of tumor cells in cerebrospinal fluid in the diagnosis of meningeal metastasis from lung cancer by immuno-FISH technology. Oncol Lett (2016) 0.75

Neuroborreliosis Mimicking Leptomeningeal Carcinomatosis in a Patient With Breast Cancer: A Case Report. J Investig Med High Impact Case Rep (2014) 0.75

Syndrome of inappropriate antidiuretic hormone in a patient with leptomeningeal carcinomatosis. J Med Case Rep (2016) 0.75

Intravenous thiotepa for treatment of breast cancer-related leptomeningeal carcinomatosis: case series. Neurol Sci (2015) 0.75

Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors. Neuro Oncol (2017) 0.75

Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer (1982) 4.40

Leptomeningeal carcinomatosis. Presenting features and prognostic factors. Arch Neurol (1996) 2.95

Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study. Arch Neurol (1974) 2.33

Ventriculoperitoneal shunt in patients with leptomeningeal metastasis. Neurology (2005) 1.91

Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases. J Neurosurg (1997) 1.74

Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol (1995) 1.71

Leptomeningeal metastasis: survival and prognostic factors in 155 patients. J Neurol Sci (2004) 1.62

Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol (1990) 1.57

Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors. J Neurooncol (2008) 1.28

Diffuse involvement of the leptomeninges by tumour--a clinical and pathological study of 63 cases. Postgrad Med J (1980) 1.10

An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis. J Neurooncol (2002) 1.10

Ommaya reservoirs in 387 cancer patients: a 15-year experience. Neurology (1985) 1.10

Leptomeningeal metastases--treatment results in 98 consecutive patients. Isr J Med Sci (1989) 1.01

Primary treatment of childhood acute lymphoblastic leukemia of non-T cell lineage (including infants). Hematol Oncol Clin North Am (1990) 1.00

The diagnostic challenge of tumors manifested initially by the shedding of cells into cerebrospinal fluid. Acta Cytol (1984) 0.92

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol (1999) 5.95

Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification. J Clin Oncol (2001) 3.06

Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients. J Clin Oncol (1998) 1.74

Stroke in patients with cancer: incidence and etiology. Neurology (2004) 1.65

Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial. Proc Natl Acad Sci U S A (2001) 1.63

Histology and outcomes of newly detected lung lesions in melanoma patients. Ann Oncol (2011) 1.43

Statistical issues in analysis of diagnostic imaging experiments with multiple observations per patient. Radiology (2001) 1.40

Evaluation of Elispot assays: influence of method and operator on variability of results. J Immunol Methods (2004) 1.36

A standardization method to adjust for the effect of patient selection in phase II clinical trials. Stat Med (2001) 1.30

Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi--results from the NYU-LCMN registry. Br J Dermatol (2005) 1.23

Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours. J Clin Pathol (2006) 1.14

A role for a melanosome transport signal in accessing the MHC class II presentation pathway and in eliciting CD4+ T cell responses. J Immunol (1999) 1.12

Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide. Int J Cancer (2000) 1.10

Ophthalmic, ultrasonographic findings in primary central nervous system lymphoma with ocular involvement. Retina (1997) 1.04

Response of LNCaP spheroids after treatment with an alpha-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591). Cancer Res (2001) 1.04

Intracerebral and subarachnoid hemorrhage in patients with cancer. Neurology (2010) 0.99

Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: a dose-response study. Clin Cancer Res (2000) 0.98

Control of fleas on pets and in homes by use of imidacloprid or lufenuron and a pyrethrin spray. J Am Vet Med Assoc (1999) 0.96

Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias. Bone Marrow Transplant (2003) 0.95

A prospective study of oral lesions and their predictive value for progression of HIV disease. Oral Dis (1997) 0.95

5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study. J Clin Oncol (1999) 0.94

Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma. Clin Cancer Res (2001) 0.90

Intralesional resection of primary and metastatic sarcoma involving the spine: outcome analysis of 59 patients. Neurosurgery (2001) 0.89

The effects of competitive road-racing on the body composition, pulmonary function, and cardiovascular system of sport cyclists. J Sports Med Phys Fitness (1981) 0.89

The utility of the Edmonton Symptom Assessment System in screening for anxiety and depression. Eur J Cancer Care (Engl) (2012) 0.87

Multimodality imaging of primary CNS lymphoma in immunocompetent patients. Br J Radiol (2014) 0.86

Phase II trial of neoadjuvant temozolomide in resectable melanoma patients. Ann Oncol (2010) 0.85

Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenografts. Int J Cancer (2000) 0.84

Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma. J Neurooncol (2005) 0.81

Oral lesions as markers of severe immunosuppression in HIV-infected homosexual men and injection drug users. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1996) 0.81

Vaccination with a bivalent G(M2) and G(D2) ganglioside conjugate vaccine: a trial comparing doses of G(D2)-keyhole limpet hemocyanin. Clin Cancer Res (2000) 0.81

Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience. Ann Oncol (2009) 0.79

The anaerobic threshold of elite and novice cyclists. J Sports Med Phys Fitness (1986) 0.78

Intradermal injection of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with metastatic melanoma recruits dendritic cells. Cytokines Cell Mol Ther (1999) 0.78

Treatment of metastatic melanoma in the brain with temozolomide and thalidomide. Lancet Oncol (2001) 0.76

Clinical results using biochemotherapy as a standard of care in advanced melanoma. Melanoma Res (2002) 0.75

Seizure prophylaxis and melanoma brain metastases. J Neurooncol (2012) 0.75

The competitive junior cyclist: indices of maximal performance. J Sports Med Phys Fitness (1979) 0.75

Specificity of training: selective aspects of running. J Sports Med Phys Fitness (1981) 0.75

Interval estimation of the common odds ratio from k(2 x 2) tables under cluster sampling. Stat Med (1999) 0.75